Arachidonic acid (AA) and docosahexaenoic acid (DHA) reduce the risk of severe retinopathy of prematurity (ROP) in extremely premature infants by almost half, according to a research paper published online in JAMA Ophthalmology.
Arachidonic acid (AA) and docosahexaenoic acid (DHA) reduce the risk of severe retinopathy of prematurity (ROP) in extremely premature infants by almost half, according to a research paper published online in JAMA Ophthalmology.